Raising at the Wrong Valuation: What It Actually Costs You Two Rounds Later

Most founders negotiate valuation harder than any other term in a term sheet. It is the number that gets announced, the number the team hears about, and the number that shows up in the congratulatory messages. It is also the number most likely to be tested by reality within eighteen months. Valuation is not a score. It is a commitment. You are contractually agreeing to grow into an expectation, and the terms sitting around that number decide what happens to you if you fall short. The cost of getting it wrong rarely shows up at signing. It shows up two rounds later, on the cap table, when there is nothing left to renegotiate.

Your valuation sets the bar for the round after next

Work the arithmetic before you accept the price.

Suppose you raise Rs 40 crore at a Rs 200 crore pre-money, so Rs 240 crore post. Institutional investors generally underwrite entry-to-next-round step-ups in the region of 2.5x to 3x. That means your next round needs to clear roughly Rs 600 crore for the round to be considered a success by the people who backed you. Now add the second effect most founders ignore: revenue multiples compress as a company scales. The 12x forward multiple that got you Rs 240 crore at Rs 20 crore of ARR is unlikely to survive at scale. Assume 8x at the next round. Rs 600 crore at 8x means roughly Rs 75 crore of ARR within 24 months.

Had you priced the same round at Rs 160 crore post, the equivalent next-round target would be around Rs 400 crore, or roughly Rs 50 crore of ARR. The extra Rs 80 crore of headline valuation quietly added Rs 25 crore of ARR to your two-year operating plan. Nobody wrote that into the shareholders' agreement. It is there anyway, and your board will hold you to it.

The term sheet quietly reprices what the headline number gets wrong

Investors are not naive about stretched valuations. If they concede on price, they usually take it back in structure.

In the Indian market the baseline is a 1x non-participating liquidation preference with broad-based weighted-average anti-dilution protection. Participating preferences and full-ratchet anti-dilution exist, but as the Chambers Venture Capital 2026 India guide notes, full ratchet shows up primarily as a stress or leverage term rather than routine practice. That distinction matters more than it appears. An aggressive valuation raises the probability that you end up in precisely the stressed scenario where those terms are triggered.

Here is the mechanism. If the next round is priced below the last, anti-dilution resets the earlier investor's effective conversion price. They receive additional shares at no extra cost. That dilution does not fall on the market. It falls on the common stock, which means founders and the ESOP pool. Under weighted-average protection the hit is moderate. Under full ratchet it can be severe. The founder who negotiated 25% more on headline valuation and accepted tighter protective terms can easily end up owning less, with less control, than the founder who took the lower number with clean documentation. The first founder had a better press release. The second has a better company.

Underpricing is also expensive, just more slowly

None of this is an argument for accepting the lowest offer.

If you raise well below what your numbers support, you hand over more of the company than the capital justifies, and that error compounds. Founder and employee ownership that drops too far too early creates two practical problems: you lose the equity currency needed to attract senior operators, and you weaken the alignment that carries a business through the difficult middle years. There is also an anchoring effect. Your Series A price shapes what a Series B investor believes your business is worth, regardless of what changed in between.

In the SME and promoter-led segment, the more frequent error is not overpricing. It is raising too little, too often, at prices set by whoever was available rather than by what the business could defend. Four small rounds priced defensively will cost you more ownership than two properly sized rounds priced accurately.

A strong funding market does not make a stretched price safer

India's venture and growth equity market absorbed roughly USD 16 billion in 2025, a second consecutive year of growth, with USD 250 million-plus deals doubling year on year and funds themselves raising around USD 5.4 billion, according to Bain & Company's India Venture Capital Report 2026.

Read that correctly. Capital availability is not your constraint, and it is not your justification either. A liquid market makes it easier to obtain a stretched price. It does nothing whatsoever to make it easier to grow into one. Available money is why founders overprice. It has never been the reason overpricing works.

How to price a round you can actually defend

Four tests are worth applying before you agree to a number. First, work backwards from the next round rather than forwards from the last one. Ask what revenue, gross margin and burn profile you need to justify 2.5x this valuation in 18 to 24 months, at a multiple 20% to 30% below today's. If your plan reaches that only in the best case, the price is wrong.

Second, budget dilution across the entire journey rather than one round at a time. Decide what founders and the team should own at exit, then work backwards through the rounds you expect to raise. Most founders discover they have already spent their dilution budget by Series A. Third, price the terms and not just the valuation. For every structural concession, model the downside case rather than the base case. A pre-money 15% lower with clean documentation is usually worth more than a headline win carrying participating preference, a ratchet or aggressive exit rights.

Fourth, raise against a milestone rather than a runway period. Capital should buy a specific, provable set of metrics that makes the next round priceable; eighteen months of runway is not a milestone. And throughout, separate what an investor will pay from what your business is worth. A fund may stretch to secure an asset it wants, but that price still becomes the bar you are measured against, and the fund will have moved on to its next investment long before you have grown into it.

The right valuation is the highest number you can grow into with room for error, on terms that will not punish you if you land 20% short. That band is narrower than most founders assume, and it usually sits below the best offer on the table. Founders who understand this negotiate differently. They trade headline value for clean terms, sharper milestones and investors with the capacity and appetite to fund the round after this one. The ones who do not spend the next two years working for a number they agreed to in a single meeting.

Disclaimer

This article is for general information only and does not constitute financial, investment, tax, legal, or professional advice. The views expressed are for general informational purposes and should not be relied upon as a substitute for advice specific to your business or circumstances. Please seek appropriate professional advice before making any business, financial, investment, or transaction-related decision.